By expenditures
| Name | Title | Type |
|---|---|---|
| Anthony Testa | BUSINESS MANAGER | Auditee |
| Martha Kew | BUSINESS MANAGER | Auditee |
| Carl Hogan, CPA | PRINCIPAL | Auditee |
| No contacts on file | ||
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 15527 | 2023 | 2024-02-05 | 588163 | 2023-002 | Significant Deficiency | - | ABGHL |
| 15527 | 2023 | 2024-02-05 | 588162 | 2023-002 | Significant Deficiency | - | ABGHL |
| 15527 | 2023 | 2024-02-05 | 588161 | 2023-002 | Significant Deficiency | - | ABGHL |
| 15527 | 2023 | 2024-02-05 | 588160 | 2023-002 | Significant Deficiency | - | ABFN |
| 15527 | 2023 | 2024-02-05 | 588159 | 2023-002 | Significant Deficiency | - | ABFN |
| 15527 | 2023 | 2024-02-05 | 588158 | 2023-002 | Significant Deficiency | - | ABFN |
| 15527 | 2023 | 2024-02-05 | 588157 | 2023-002 | Significant Deficiency | - | ABFN |
| 15527 | 2023 | 2024-02-05 | 588156 | 2023-001 | Material Weakness | Yes | ABGHL |
| 15527 | 2023 | 2024-02-05 | 588155 | 2023-001 | Material Weakness | Yes | ABGHL |
| 15527 | 2023 | 2024-02-05 | 588154 | 2023-001 | Material Weakness | Yes | ABGHL |
| 15527 | 2023 | 2024-02-05 | 588153 | 2023-001 | Material Weakness | Yes | ABFN |
| 15527 | 2023 | 2024-02-05 | 588152 | 2023-001 | Material Weakness | Yes | ABFN |
| 15527 | 2023 | 2024-02-05 | 588151 | 2023-001 | Material Weakness | Yes | ABFN |
| 15527 | 2023 | 2024-02-05 | 588150 | 2023-001 | Material Weakness | Yes | ABFN |
| 15527 | 2023 | 2024-02-05 | 11721 | 2023-002 | Significant Deficiency | - | ABGHL |
| 15527 | 2023 | 2024-02-05 | 11720 | 2023-002 | Significant Deficiency | - | ABGHL |
| 15527 | 2023 | 2024-02-05 | 11719 | 2023-002 | Significant Deficiency | - | ABGHL |
| 15527 | 2023 | 2024-02-05 | 11718 | 2023-002 | Significant Deficiency | - | ABFN |
| 15527 | 2023 | 2024-02-05 | 11717 | 2023-002 | Significant Deficiency | - | ABFN |
| 15527 | 2023 | 2024-02-05 | 11716 | 2023-002 | Significant Deficiency | - | ABFN |
| 15527 | 2023 | 2024-02-05 | 11715 | 2023-002 | Significant Deficiency | - | ABFN |
| 15527 | 2023 | 2024-02-05 | 11714 | 2023-001 | Material Weakness | Yes | ABGHL |
| 15527 | 2023 | 2024-02-05 | 11713 | 2023-001 | Material Weakness | Yes | ABGHL |
| 15527 | 2023 | 2024-02-05 | 11712 | 2023-001 | Material Weakness | Yes | ABGHL |
| 15527 | 2023 | 2024-02-05 | 11711 | 2023-001 | Material Weakness | Yes | ABFN |
| 15527 | 2023 | 2024-02-05 | 11710 | 2023-001 | Material Weakness | Yes | ABFN |
| 15527 | 2023 | 2024-02-05 | 11709 | 2023-001 | Material Weakness | Yes | ABFN |
| 15527 | 2023 | 2024-02-05 | 11708 | 2023-001 | Material Weakness | Yes | ABFN |
| 28232 | 2022 | 2023-04-17 | 608821 | 2022-001 | Material Weakness | - | ABILN |
| 28232 | 2022 | 2023-04-17 | 608820 | 2022-001 | Material Weakness | - | ABILN |
| 28232 | 2022 | 2023-04-17 | 608819 | 2022-001 | Material Weakness | - | ABILN |
| 28232 | 2022 | 2023-04-17 | 608818 | 2022-001 | Material Weakness | - | ABFN |
| 28232 | 2022 | 2023-04-17 | 608817 | 2022-001 | Material Weakness | - | ABFN |
| 28232 | 2022 | 2023-04-17 | 608816 | 2022-001 | Material Weakness | - | ABFN |
| 28232 | 2022 | 2023-04-17 | 608815 | 2022-001 | Material Weakness | - | ABFN |
| 28232 | 2022 | 2023-04-17 | 608814 | 2022-001 | Material Weakness | - | ABFN |
| 28232 | 2022 | 2023-04-17 | 32379 | 2022-001 | Material Weakness | - | ABILN |
| 28232 | 2022 | 2023-04-17 | 32378 | 2022-001 | Material Weakness | - | ABILN |
| 28232 | 2022 | 2023-04-17 | 32377 | 2022-001 | Material Weakness | - | ABILN |
| 28232 | 2022 | 2023-04-17 | 32376 | 2022-001 | Material Weakness | - | ABFN |
| 28232 | 2022 | 2023-04-17 | 32375 | 2022-001 | Material Weakness | - | ABFN |
| 28232 | 2022 | 2023-04-17 | 32374 | 2022-001 | Material Weakness | - | ABFN |
| 28232 | 2022 | 2023-04-17 | 32373 | 2022-001 | Material Weakness | - | ABFN |
| 28232 | 2022 | 2023-04-17 | 32372 | 2022-001 | Material Weakness | - | ABFN |